65
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection

, , , , , , , , & show all
Pages 493-500 | Published online: 26 Aug 2013

References

  • CarrACooperDAAdverse effects of antiretroviral therapyLancet20003561423143011052597
  • WalliRHerfortOMichlGMTreatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patientsAIDS199812F167F1739814858
  • VergisENPatersonDLWagenerMMSwindellsSSinghNDyslipidemia in HIV-infected patients: association with adherence to potent antiretroviral therapyInt J STD AIDS20011246346811394983
  • GalliMRidolfoALAdorniFBody habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitorsJ Acquir Immune Defic Syndr200229213111782586
  • Friis-MøllerNWeberRReissPDAD study groupCardiovascular risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS2003171179119312819520
  • CarrASamarasKThorisdottirAKaufmannGRChisholmDJCooperDADiagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort studyLancet19993532093209910382692
  • Friis-MøllerNSabinCAWeberRData Collection on Adverse Events of Anti-HIV Drugs (DAD) Study GroupCombination antiretroviral therapy and the risk of myocardial infarctionN Engl J Med20033491993200414627784
  • BozzetteSAAkeCFTamHKChangSWLouisTACardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infectionN Engl J Med200334870271012594314
  • ClarkLTFerdinandKCFlackJMCoronary heart disease in African AmericansHeart Dis2001329710811975778
  • HarrisSSDoes vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans?Am J Clin Nutr20119351175S1178S21367947
  • CamargoCAJrVitamin D and cardiovascular disease time for large randomized trialsJ Am Coll Cardiol201158141442144421939826
  • LeeJHO’KeefeJHBellDHensrudDDHolickMFVitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?J Am Coll Cardiol2008521949195619055985
  • WangTJPencinaMJBoothSLVitamin D deficiency and risk of cardiovascular diseaseCirculation200811750351118180395
  • LaiHFishmanEGerstenblithGVitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine usersInt J Cardiol2012158221121621295360
  • LaiHDetrickBFishmanEKVitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary studyJ Investig Med2012605801807
  • LaiHGerstenblithGFishmanEKVitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infectionClin Infect Dis201254121747175522423137
  • DetranoRGuerciADCarrJJCoronary calcium as a predictor of coronary events in four racial or ethnic groupsN Engl J Med20083581336134518367736
  • ErsfeldDLRaoDSBodyJJAnalytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzerClin Biochem20043786787415369717
  • HosmerDWLemeshowSApplied Logistic RegressionNew York, NYJohn Wiley and Sons1989
  • WilsonPWD’AgostinoRBLevyDBelangerAMSilbershatzHKannelWBPrediction of coronary heart disease using risk factor categoriesCirculation199897183718479603539
  • LaiSFishmanEKLaiHLong-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in African Americans with HIV infection who have no cardiovascular symptomsClin Infect Dis20084660061019641630
  • MengQLimaJACLaiHCoronary artery calcification, atherogenic lipid changes and increased erythrocyte volume in HIV-1 infected participants treated with protease inhibitorsAm Heart J2002144464264812360160
  • MengQLimaJACLaiHUse of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunctionJ Acquir Immune Defic Syndr20023030631012131567
  • LaiSLaiHMengQEffect of cocaine use on coronary calcification among black adults in BaltimoreAm J Cardiol20029032632812127624
  • MengQLimaJALaiHElevated C- reactive protein levels are associated with endothelial dysfunction in chronic cocaine usersInt J Cardiol20038819119812714198
  • LaiSLaiHCelentanoDDFactors associated with accelerated atherosclerosis in hiv-1-infected persons treated with protease inhibitorsAIDS Patient Care STDS200317521121912816615
  • TongWLimaJALaiHCelentanoDDDaiSLaiSRelation of coronary artery calcium to left ventricular mass in African AmericansAm J Cardiol20049349049214969633
  • TongWLimaJAMengQFlynnELaiSLong-term cocaine use is related to cardiac diastolic dysfunction in an African-American population in Baltimore, MarylandInt J Cardiol200497252815336802
  • LaiSLimaJALaiHHuman immunodeficiency virus 1 infection, cocaine, and coronary calcificationArch Intern Med200516569069515795348
  • MengQYDuJFLaiHLaiSHCoronary artery calcification is associated with atherogenic lipid changes, cardiac dysfunction and morphologic abnormalities in HIV-1 infected black adultsChin Med J (Engl)2005118541241415780212
  • RenSTongWLaiHOsmanNFPannuHLaiSEffect of long-term cocaine use on regional left ventricular function as determined by magnetic resonance imagingAm J Cardiol2006971085108816563922
  • LaiSBartlettJLaiHLong-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infectionAIDS Patient Care STDs2009231081582419803679
  • GargHJoshiAMukherjeeDCardiovascular complications of HIV infection and treatmentCardiovasc Hematol Agents Med Chem2013111586622946901
  • PériardDTelentiASudrePAtherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort StudyCirculation1999100770070510449690
  • ThomasCMSmartEJHow HIV protease inhibitors promote atherosclerotic lesion formationCurr Opin Lipidol200718556156517885428
  • JiangBHebertVYZaveczJHDugasTRAntiretrovirals induce direct endothelial dysfunction in vivoJ Acquir Immune Defic Syndr200642439139516810107
  • ChaiHYangHYanSEffects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteriesJ Acquir Immune Defic Syndr2005401121916123675
  • SteinJHKleinMABellehumeurJLUse of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunctionCirculation200110425726211457741
  • BehrensJMBoernerARWeberKImpaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophyJ Clin Invest20021101319132712417571
  • DressmanJKincerJMatveevSVHIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophagesJ Clin Invest200311138939712569165
  • SeminariEPanAVoltiniGAssessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitorsAtherosclerosis200216243343811996964
  • MailletMChiarasiniDNahasGMyocardial damage induced by cocaine administration of a week’s duration in the ratAdv Biosci199180187197
  • RisnerMEJonesBEIntravenous self-administration of cocaine and norcocaine by dogsPsychopharmacology (Berl)19807183896779329
  • LangnerROPerryLFHeavilinDThe cardiovascular toxicity of cocaine in the rabbit (abstract)Fed Proc1983421360
  • KolodgieFDVirmaniRRiceHEIntravenous cocaine accelerates atherosclerosis in cholesterol-fed New Zealand White rabbits (abstract)J Am Coll Cardiol1990152217A
  • TognaGTempestaETognaARDolciNCeboBCaprinoLPlatelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatmentHaemostasis1985151001073924789
  • HolickMFBinkleyNCBischoff-FerrariHAEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineJ Clin Endocrinol Metab2011961911193021646368
  • HolickMFVitamin D deficiencyN Engl J Med200735726628117634462
  • GelfandJMCreeBAMcElroyJVitamin D in African Americans with multiple sclerosisNeurology201176211824183021606454
  • KendrickJTargherGSmitsGChoncholM25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination SurveyAtherosclerosis200920525526019091317
  • de BoerIHKestenbaumBShobenABMichosEDSarnakMJSiscovickDS25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcificationJ Am Soc Nephrol20092081805181219443637
  • Reddy VangaSGoodMHowardPAVacekJLRole of vitamin D in cardiovascular healthAm J Cardiol2010106679880520816120
  • TarcinOYavuzDGOzbenBEffect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjectsJ Clin Endocrinol Metab2009944023403019584181
  • SugdenJADaviesJIWithamMDMorrisADStruthersADVitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levelsDiabet Med20082532032518279409
  • TareMEmmettSJColemanHAVitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young ratsJ Physiol2011589Pt 194777478621807617
  • ZittermannASchleithoffSSKoerferRVitamin D and vascular calcificationCurr Opin Lipidol2007181414617218831
  • ZittermannAVitamin D in preventive medicine: are we ignoring the evidence?Br J Nutr200389555257212720576
  • ZehnderDBlandRChanaRSSynthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by infammatory cytokines: a novel autocrine determinant of vascular cell adhesionJ Am Soc Nephrol200213362162911856765
  • SpenceLAWeaverCMCalcium intake, vascular calcification, and vascular diseaseNutr Rev2013711152223282248
  • ReidIRBollandMAvenellAGreyACardiovascular effects of calcium supplementationOsteoporos Int2011221649165821409434